Masimo (MASI) Stock Forecast, Price & News

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last year. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" MASI shares.
View MASI analyst ratings or view top-rated stocks.

8 equities research analysts have issued 1-year price objectives for Masimo's stock. Their MASI share price forecasts range from $150.00 to $207.00. On average, they predict the company's share price to reach $188.88 in the next twelve months. This suggests a possible upside of 14.2% from the stock's current price.
View analysts price targets for MASI or view top-rated stocks among Wall Street analysts.

Masimo's stock was trading at $147.95 on January 1st, 2023. Since then, MASI shares have increased by 11.7% and is now trading at $165.32.
View the best growth stocks for 2023 here.

Masimo saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 1,070,000 shares, an increase of 23.6% from the April 30th total of 865,600 shares. Based on an average daily volume of 369,600 shares, the short-interest ratio is presently 2.9 days. Approximately 2.2% of the company's shares are sold short.
View Masimo's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our MASI earnings forecast.

Masimo Co. (NASDAQ:MASI) released its earnings results on Tuesday, May, 9th. The medical equipment provider reported $0.87 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.83 by $0.04. The medical equipment provider had revenue of $565 million for the quarter, compared to analysts' expectations of $557.87 million. Masimo had a trailing twelve-month return on equity of 19.32% and a net margin of 5.16%. Masimo's revenue was up 85.7% on a year-over-year basis. During the same period in the previous year, the business posted $0.93 earnings per share.

ETFs with the largest weight of Masimo (NASDAQ:MASI) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Invesco DWA Healthcare Momentum ETF (PTH), First Trust Indxx Medical Devices ETF (MDEV), Global X Founder-Run Companies ETF (BOSS), ERShares Entrepreneurs ETF (ENTR), BlackRock Future Health ETF (BMED) and Neuberger Berman Disrupters ETF (NBDS).

Masimo updated its FY23 earnings guidance on Tuesday, May, 9th. The company provided earnings per share guidance of $4.70-4.80 for the period, compared to the consensus EPS estimate of $4.76. The company issued revenue guidance of $2.415-2.460 billion, compared to the consensus revenue estimate of $2.44 billion.

136 employees have rated Masimo Chief Executive Officer Joe E. Kiani on Glassdoor.com. Joe E. Kiani has an approval rating of 90% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Masimo investors own include NVIDIA (NVDA), Netflix (NFLX), Shopify (SHOP), Okta (OKTA), PayPal (PYPL), Alibaba Group (BABA), Mastercard (MA), Trade Desk (TTD), Walt Disney (DIS) and Twilio (TWLO).

Masimo trades on the NASDAQ under the ticker symbol "MASI."

Masimo's stock is owned by a number of institutional and retail investors. Top institutional investors include FMR LLC (11.57%), BlackRock Inc. (11.30%), State Street Corp (3.24%), Liontrust Investment Partners LLP (1.80%), Geode Capital Management LLC (1.38%) and Farallon Capital Management LLC (1.20%). Insiders that own company stock include Adam Mikkelson, Anand Sampath, Bilal Muhsin, Craig B Reynolds, H Michael Cohen, Joe E Kiani, Jon Coleman, Micah W Young, Tao Levy and Thomas Samuel Mcclenahan.
View institutional ownership trends.

Shares of MASI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MASI stock can currently be purchased for approximately $165.32.

Masimo (NASDAQ:MASI) has a market capitalization of $8.73 billion and generates $2.04 billion in revenue each year. The medical equipment provider earns $143.50 million in net income (profit) each year or $2.18 on an earnings per share basis.

The company employs 6,000 workers across the globe.

Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The official website for the company is www.masimo.com. The medical equipment provider can be reached via phone at (949) 297-7000, via email at ekammerman@masimo.com, or via fax at 949-297-7001.